The Valley Desk

Clinical trial reportThe lancet. Gastroenterology & hepatologyPublished

Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The lancet. Gastroenterology & hepatology
Published
Subject terms
Humans; Colitis, Ulcerative; Treatment Outcome; Injections, Subcutaneous; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male; Interleukin-23 Subunit p19; Antibodies, Monoclonal, Humanized
PubMed ID
41544637
Added to directory
Source checked

Report a correction or request removal